Three investment funds with holdings in Spanish drugmaker Grifols have teamed up to ask to fill a vacant seat on the company’s board, they said in a statement late on Thursday.
They said Grifols, which produces plasma-based medicines, had “an attractive growth profile” and its shares were undervalued and they wanted to make sure any takeover offer would include “a price that is fair for all shareholders”.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: